RESEARCHER PROFILE
David A Nolan
← Back to Dublin City University
D
Dublin City University
David A Nolan works in HIV/AIDS drug development and treatment, HIV-related health complications and treatments, HIV Research and Treatment, Drug-Induced Adverse Reactions, HIV/AIDS Research and Interventions. Recorded institutional associations include Dublin City University.
213Publications
9,704Citations
45H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
HLA-B*5701 Screening for Hypersensitivity to Abacavir
2008 · 1,835 citationsAssociation between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
2002 · 1,380 citationsPredisposition to abacavir hypersensitivity conferred by HLA-B * 5701 and a haplotypic Hsp70-Hom variant
2004 · 452 citationsApolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease
2006 · 388 citationsHuman Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity
2008 · 334 citationsPredisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts
2004 · 317 citationsProspective Genetic Screening Decreases the Incidence of Abacavir Hypersensitivity Reactions in the Western Australian HIV Cohort Study
2006 · 296 citationsMitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy
2003 · 265 citationsClinical and immunogenetic correlates of abacavir hypersensitivity
2005 · 198 citationsStable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir
2001 · 163 citationsPopulation Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation
2006 · 132 citationsContribution of Nucleoside-Analogue Reverse Transcriptase Inhibitor Therapy to Lipoatrophy from the Population to the Cellular Level
2003 · 129 citationsKiller immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression
2005 · 128 citationsRandomized, Controlled, 48-Week Study of Switching Stavudine and/or Protease Inhibitors to Combivir/Abacavir to Prevent or Reverse Lipoatrophy in HIV-Infected Patients
2003 · 112 citationsMetabolic Complications Associated with HIV Protease Inhibitor Therapy
2003 · 97 citationsComplications Associated with Nrti Therapy: Update on Clinical Features and Possible Pathogenic Mechanisms
2004 · 96 citationsAntiretroviral Therapy and the Lipodystrophy Syndrome
2001 · 95 citationsInterferon‐alpha, immune activation and immune dysfunction in treated HIV infection
2014 · 95 citationsOestrogen replacement therapy may improve memory functioning in the absence of APOE ε4
2004 · 94 citationsAccumulation of Mitochondrial DNA Mutations in Human Immunodeficiency Virus–Infected Patients Treated with Nucleoside-Analogue Reverse-Transcriptase Inhibitors
2003 · 93 citationsHIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection
2013 · 90 citationsMitochondrial Proliferation, Dna Depletion and Adipocyte Differentiation in Subcutaneous Adipose Tissue of HIV-Positive Haart Recipients
2003 · 84 citationsPlasma Aβ42 correlates positively with increased body fat in healthy individuals
2005 · 75 citationsA Visfatin Promoter Polymorphism Is Associated with Low‐Grade Inflammation and Type 2 Diabetes
2006 · 75 citationsMapping the Landscape of Host-Pathogen Coevolution: HLA Class I Binding and Its Relationship with Evolutionary Conservation in Human and Viral Proteins
2010 · 74 citations
